Akhilesh calls Modi's tour during Ramzan 'international appeasement' of Muslims

Agencies
June 5, 2018

Lucknow, Jun 5: Samajwadi Party chief Akhilesh Yadav on Monday asked if Prime Minister Narendra Modi’s recent visit to Indonesia and Malaysia during the month of Ramzan was an attempt towards “international appeasement” of the minority community.

During an interview with news agency PTI, he claimed that the people of not only Uttar Pradesh, but of the entire country were upset with the Bharatiya Janata Party (BJP) as other than making promises it “did nothing else”.

Citing a proverb, Akhilesh Yadav said, “With empty stomach, people have now understood that the BJP does not mean business.”

Asking the BJP to restrain its leaders from making “absurd” comments, he said, “The BJP should learn to face defeats or else they will be not be able to digest the outcome of the 2019 Lok Sabha elections in which the Opposition will stage a comeback.”

Slamming the BJP for accusing his party of practising minority appeasement, the Samajwadi Party chief said, “Chief Minister Yogi Adityanath says he does not celebrate Eid as he is a Hindu. The BJP charges us with practising Muslim appeasement. Modi has just visited Indonesia and Malaysia during the month of Ramzan. Is it an attempt towards ‘international appeasement’ of the Muslims?”

Adityanath had reportedly said that he is a Hindu and does not celebrate Eid, drawing sharp criticism from the Opposition.

Prime Minister Narendra Modi was for the first time on an official visit to Indonesia - the world’s most populous Muslim-majority nation - last month. He has visited Singapore twice and Malaysia once in 2015.

Modi also visited Indonesia’s grand Istiqlal Mosque, the largest in southeast Asia, with President Joko Widodo.

Indonesia is not only the world’s most populous Muslim country, followed by India, but the third largest democracy. Hindus comprise 2 per cent of Indonesia’s population and form close to a 90 per cent majority on the island of Bali.

Comments

Kannadiga
 - 
Tuesday, 5 Jun 2018

A pre-planned publicity  just to fool the public and rest of the country. Main intention is to show as innocent from  present  ongoing all communal attack and arsenal in INDIA .

These anti national groups  think '' Attacking with close eye" rest of the  world cannot see who is culprit. It is rss main agenda,  now with bjp lable they functioning. Our present cm also a leading member of rss.

 

 

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
March 4,2020

Tokyo, Mar 4: Takeda Pharmaceutical Co said on Wednesday it was developing a drug to treat COVID-19, the flu-like illness that has struck more than 90,000 people worldwide and killed over 3,000.

The Japanese drugmaker is working on a plasma-derived therapy to treat high-risk individuals infected with the new coronavirus and will share its plans with members of the U.S. Congress on Wednesday, it said in a statement.

Takeda is also studying whether its currently marketed and pipeline products may be effective treatments for infected patients.

"We will do all that we can to address the novel coronavirus threat...(and) are hopeful that we can expand the treatment options," Rajeev Venkayya, president of Takeda's vaccine business, said in the statement.

Takeda said it was in talks with various health and regulatory agencies and healthcare partners in the United States, Asia and Europe to move forward its research into the drug.

Its research requires access to the blood of people who have recovered from the respiratory disease or who have been vaccinated, once a vaccine is developed, Takeda said.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
Agencies
August 4,2020

New Delhi, Aug 4: Over 50 per cent of COVID-19 deaths in India have taken place among people aged 60 years and above and 37 per cent deaths have been reported among patients in the age group of 45 to 60 years, Health Ministry said on Tuesday.

Addressing a press conference, Rajesh Bhushan, Secretary, Health Ministry said that 11 per cent COVID-19 deaths took place in the age group of 26 to 44.

The 18 to 25 age group and those below 18 years reported one per cent deaths each.
"Currently, 5,86,298 active COVID-19 cases are in India and over 12 lakh people have recovered.

50 per cent deaths due to COVID19 have taken place among the age group of 60 years or above and 37 per cent deaths took place in the age group between 45 to 60 years," Bhushan said.

"A total of 11 per cent COVID-19 deaths took place in the age group of 26 to 44. Only 1 per cent in 18 to 25 age group and 1 per cent in below the age of 18 years," he added.

Bhushan said that 68 per cent of COVID-19 deaths have been reported among male patients and 32 per cent among female patients which is broadly in line with the global scenario.

The number of recovered COVID-19 patients in India is increasing daily and is now over double the number of active cases.

Bhushan said that the case fatality rate (CFR) is lowest since the first lockdown.

"More than 2 crore COVID-19 tests have been conducted, including more than 6.6 lakh tests in the last 24 hours. Recovered cases are now double of the active cases. 

The case fatality rate (CFR) is lowest since the first lockdown," he said
"This is the first time after the first lockdown that the fatality rate is at the lowest, at 2.10 per cent. The fatality rate has seen a progressive decline and it is continuing, which is a good sign," he added.

According to the World Health Organisation, CFR is a measure of the severity of a disease and is defined as the proportion of reported cases of a specified disease or condition which are fatal within a specified time.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
Agencies
February 4,2020

New Delhi, Feb 4: Saying the matter had been adjourned many times and it will have to hear it someday, the Supreme Court on Tuesday fixed April 14 for hearing a plea by Zakia Jafri, wife of slain MP Ehsan Jafri, challenging the SIT's clean chit to then Gujarat chief minister Narendra Modi in the 2002 riots.

A bench comprising Justices A M Khanwilkar and Dinesh Maheshwari posted the matter for hearing in April after Zakia's counsel sought an adjournment and urged the court to post it after the Holi vacation.

When advocate Aparna Bhat, appearing for Zakia, told the court that the issue in the matter is contentious, the bench said, "It has been adjourned so many times, whatever it is, we will have to hear it someday. Take one date and make sure you all are available." Zakia had filed a petition in the apex court in 2018 challenging the Gujarat High Court's October 5, 2017 order rejecting her plea against the decision of the Special Investigation Team.

Ehsan Jafri was among the 68 people killed at Gulberg Society on February 28, 2002, a day after the S-6 Coach of the Sabarmati Express was burnt at Godhra killing 59 people and triggering riots in Gujarat.

On February 8, 2012, the SIT filed a closure report giving a clean chit to Modi and 63 others, including senior government officials, saying there was "no prosecutable evidence" against them.

Comments

Althaf
 - 
Tuesday, 4 Feb 2020

No use.. will Supreme court gives justice??? 

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.